Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Amneal
Pharma
Amneal ponies up $1.1B for biosimilars specialist Kashiv
Generics leader Amneal has bought out Kashiv BioSciences for $1.1 billion in an effort to take advantage of the booming biosimilars market.
Kevin Dunleavy
Apr 22, 2026 11:32am
Amneal recalls generic antibiotic due to contamination
Jun 5, 2025 10:15am
Amneal recalls 2 lots of hospital med over contamination fears
Apr 21, 2025 10:35am
Teva notches loss in inhaler patent case against Amneal
Jun 12, 2024 9:35am
GSK, Amneal and Kaleo walk back patents after FTC's challenge
Dec 21, 2023 11:08am
Samsung, Olympus, Dr. Reddy's—Fierce Pharma Asia
Mar 3, 2023 9:45am
